532 related articles for article (PubMed ID: 1379221)
1. Effects of recombinant canine granulocyte colony-stimulating factor on white blood cell production in clinically normal and neutropenic dogs.
Mishu L; Callahan G; Allebban Z; Maddux JM; Boone TC; Souza LM; Lothrop CD
J Am Vet Med Assoc; 1992 Jun; 200(12):1957-64. PubMed ID: 1379221
[TBL] [Abstract][Full Text] [Related]
2. Effects of recombinant granulocyte colony-stimulating factor treatment on hematopoietic cycles and cellular defects associated with canine cyclic hematopoiesis.
Pratt HL; Carroll RC; McClendon S; Smathers EC; Souza LM; Lothrop CD
Exp Hematol; 1990 Dec; 18(11):1199-203. PubMed ID: 1699776
[TBL] [Abstract][Full Text] [Related]
3. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
4. Hematologic improvement in dogs with parvovirus infection treated with recombinant canine granulocyte-colony stimulating factor.
Duffy A; Dow S; Ogilvie G; Rao S; Hackett T
J Vet Pharmacol Ther; 2010 Aug; 33(4):352-6. PubMed ID: 20646196
[TBL] [Abstract][Full Text] [Related]
5. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
Iguchi K; Inoue S; Kumar A
Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil function in normal and Chediak-Higashi syndrome cats following administration of recombinant canine granulocyte colony-stimulating factor.
Colgan SP; Gasper PW; Thrall MA; Boone TC; Blancquaert AM; Bruyninckx WJ
Exp Hematol; 1992 Nov; 20(10):1229-34. PubMed ID: 1385198
[TBL] [Abstract][Full Text] [Related]
7. Use of recombinant canine granulocyte colony-stimulating factor to decrease myelosuppression associated with the administration of mitoxantrone in the dog.
Ogilvie GK; Obradovich JE; Cooper MF; Walters LM; Salman MD; Boone TC
J Vet Intern Med; 1992; 6(1):44-7. PubMed ID: 1372355
[TBL] [Abstract][Full Text] [Related]
8. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo activity of human recombinant granulocyte-macrophage colony-stimulating factor in dogs.
Mayer P; Werner FJ; Lam C; Besemer J
Exp Hematol; 1990 Oct; 18(9):1026-33. PubMed ID: 2168838
[TBL] [Abstract][Full Text] [Related]
10. G-CSF is a major component of colony-stimulating activity (CSA) in the plasma of patients with multiple myeloma after treatment with high-dose melphalan (HDM).
Joffe JK; Bell JB; Denham S; Adshead F; Millar JL; Millar BC
Exp Hematol; 1995 Apr; 23(4):376-82. PubMed ID: 7534716
[TBL] [Abstract][Full Text] [Related]
11. Myeloid progenitor cell growth characteristics and effect of G-CSF in a patient with congenital cyclic neutropenia.
Tsunogake S; Nagashima S; Maekawa R; Takano N; Kajitani H; Saito K; Enokihara H; Furusawa S; Shishido H
Int J Hematol; 1991 Jun; 54(3):251-6. PubMed ID: 1720982
[TBL] [Abstract][Full Text] [Related]
12. Recombinant canine granulocyte colony-stimulating factor accelerates recovery from cyclophosphamide-induced neutropenia in dogs.
Yamamoto A; Fujino M; Tsuchiya T; Iwata A
Vet Immunol Immunopathol; 2011 Aug; 142(3-4):271-5. PubMed ID: 21645930
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells.
Neelis KJ; Dubbelman YD; Qingliang L; Thomas GR; Eaton DL; Wagemaker G
Exp Hematol; 1997 Sep; 25(10):1084-93. PubMed ID: 9293906
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: a pilot trial.
Bernstein SH; Christiansen NP; Fay JP; Brown R; Herzig R; Frankel S; Blumenson L; Herzig GP
Exp Hematol; 1996 Oct; 24(12):1363-8. PubMed ID: 8913281
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation.
Shimazaki C; Uchiyama H; Fujita N; Araki S; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Haruyama H
Exp Hematol; 1995 Dec; 23(14):1497-502. PubMed ID: 8542937
[TBL] [Abstract][Full Text] [Related]
16. Use of recombinant human granulocyte colony-stimulating factor prior to autologous bone marrow transplantation in dogs with lymphoma.
Lane AE; Chan MJ; Wyatt KM
Am J Vet Res; 2012 Jun; 73(6):894-9. PubMed ID: 22620705
[TBL] [Abstract][Full Text] [Related]
17. The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count.
Cairo MS; Plunkett JM; Schendel P; van de Ven C
Exp Hematol; 1994 Oct; 22(11):1118-23. PubMed ID: 7523164
[TBL] [Abstract][Full Text] [Related]
18. Use of recombinant canine granulocyte-colony stimulating factor to increase leukocyte count in dogs naturally infected by canine parvovirus.
Armenise A; Trerotoli P; Cirone F; De Nitto A; De Sario C; Bertazzolo W; Pratelli A; Decaro N
Vet Microbiol; 2019 Apr; 231():177-182. PubMed ID: 30955806
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human granulocyte-colony stimulating factor: in vivo effects on myelopoiesis in primates.
Welte K; Bonilla MA; Gillio AP; Gabrilove JL; O'Reilly RJ; Souza LM
Behring Inst Mitt; 1988 Aug; (83):102-6. PubMed ID: 2467644
[TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant human granulocyte colony-stimulating factor on neutrophil function in vitro and in vivo following chemotherapy and autologous bone marrow transplantation.
Humphreys JM; Rugman FP; Davies JM; Mimnagh P; Hart CA; Edwards SW
J Clin Lab Immunol; 1991 Feb; 34(2):55-61. PubMed ID: 1725883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
